Alprazolam in panic disorder and agoraphobia: results from a multicenter trial. I. Efficacy in short-term treatment.
about
World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for the Pharmacological Treatment of Anxiety, Obsessive-Compulsive and Posttraumatic Stress DisordersCan Interoception Improve the Pragmatic Search for Biomarkers in Psychiatry?An animal model of panic vulnerability with chronic disinhibition of the dorsomedial/perifornical hypothalamusEtiology, triggers and neurochemical circuits associated with unexpected, expected, and laboratory-induced panic attacksParoxetine efficacy in the treatment of generalized anxiety disorderFluvoxamine pharmacotherapy of anxiety disorders in later life: preliminary open-trial data.Commentary: the use of placebos in psychiatric research.The Role of High-Potency Benzodiazepines in the Treatment of Panic Disorder.Evaluation of JNJ-54717793 a Novel Brain Penetrant Selective Orexin 1 Receptor Antagonist in Two Rat Models of Panic Attack Provocation.Fluoxetine in panic disorder: pharmacologic and tritiated platelet imipramine and paroxetine binding study.Panic: course, complications and treatment of panic disorder.New developments in panic disorder.Management of anxiety disorders: the added challenge of comorbidity.Psychopharmacology of anxiety disorders.The role of alprazolam for the treatment of panic disorder in Australia.Clinical pharmacology, clinical efficacy, and behavioral toxicity of alprazolam: a review of the literature.Anxiety and Depression: Optimizing Treatments.Alprazolam-induced hypomania.Anxiety disorders and major depression, together or apart.The prediction of nonresponse to pharmacotherapy in panic disorder: a review.Is Mandatory Prospective Trial Registration Working to Prevent Publication of Unregistered Trials and Selective Outcome Reporting? An Observational Study of Five Psychiatry Journals That Mandate Prospective Clinical Trial Registration.The search for new off-label indications for antidepressant, antianxiety, antipsychotic and anticonvulsant drugs.World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for the pharmacological treatment of anxiety, obsessive-compulsive and post-traumatic stress disorders - first revision.Dealing with sadness, madness and hostility. New psychotropic drug remedies for the future.Breathing training for treating panic disorder. Useful intervention or impediment?Treatment-resistant panic disorder.Role of progesterone and other neuroactive steroids in anxiety disorders.Paroxetine in panic disorder: clinical management and long-term follow-up.Panic disorder. Recognizing and managing the 'real thing'.Selective GABAergic treatment for panic? Investigations in experimental panic induction and panic disorder.A guide to benzodiazepine selection. Part II: Clinical aspects.GABAA receptors as targets for novel anxiolytic drugs.Overview of panic disorder.Acute shift in glutamate concentrations following experimentally induced panic with cholecystokinin tetrapeptide--a 3T-MRS study in healthy subjectsManagement of panic disorders.Anxiety, depression, and substance use disorders: diagnosis, treatment, and prescribing practices.Comparison of combined psycho- and pharmacotherapy with monotherapy in anxiety disorders: controversial viewpoints and clinical perspectives.Using meta-analysis in psychiatric research.Panic symptoms at the interface of body and mind.Changes in cerebral blood flow after cognitive behavior therapy in patients with panic disorder: a SPECT study.
P2860
Q22305681-18E7D9D5-660C-417D-B58F-358EF8AFDD2BQ26738449-7F5C313C-AEE8-48A9-8425-D51F9B414E0CQ27008085-6C1AD1AF-AA36-460D-B1EA-31BFC41B2AE7Q27026213-4939E73E-CC9A-4CBE-803A-1BD729B067A6Q28241959-1C83E0F8-AE40-4A65-84C0-7BEBA72E8B91Q30588902-49EA6714-9D50-40B5-9F7B-40DE864E1C7AQ33665350-AA678C7F-1A71-4747-9841-F8C4EB7D2892Q33740428-05C55C54-C5AE-4904-AFC7-265E77BE48FFQ33780634-AD8973F8-3327-4F7F-B09D-6DC036289B2DQ33921564-8ADD7CBD-B641-4D76-B218-C39C1DB9E603Q33963425-1E100C17-B6E5-499A-8E57-DCD6BA231E6FQ34108487-06C3CA29-D80F-4869-82AD-8B9DBED24EF8Q34218830-1D37816D-99A8-4738-8BC6-A92E2DB8845EQ34228150-89F65255-AC3E-43B9-A789-282690E6C5A3Q34258725-2B291B0B-1606-444D-B37C-224311983313Q34300348-3703FDB5-CADD-4F91-9A77-327D39DEDFA8Q34304950-5B1CEB5F-C986-4ACD-976A-EB0EEF7000F5Q34404353-3EC8E7DB-1D6C-4FD7-9ABD-829487FB435FQ34415535-CDBA5BCF-C475-40E1-8DCD-83C4F963F843Q34415549-1350506F-076F-4632-A490-0952E8D9367BQ34490152-E87A7880-6239-437F-95B3-B9C2488639E9Q34525841-1C1AEC59-18AD-4C7F-B019-69B3C0A52FF3Q34865036-A3E11349-CE5B-4C2C-B955-BB06711507F2Q35530687-C474FE87-6873-442F-9A38-948246036B16Q35553002-2C83847A-1BCA-426B-86E4-11080E08C126Q35901886-D4AA3190-6D54-4ED3-83C0-E16E2B9A9DF4Q36106869-4A3A73DB-2EC4-40FA-9A68-C91A48A96427Q36107073-37FF5F64-57C0-482A-ADE9-2D15DA709E53Q36127525-21A20AC0-ACFC-4A49-B343-50902609C72CQ36156471-E6B5AADC-9469-429B-9765-966F02A01251Q36495354-68DAE3DA-338A-4E05-8585-864F97B5F15CQ36637673-C2B752FB-F51A-4E34-91AB-7F171E111803Q36647657-5E1AE3FE-8347-43C5-96F4-6C02EEFE6AF2Q37030195-2F9D740D-C85F-4161-AC98-0B7F9422547DQ37042373-638058EB-02A6-4627-B1FD-3639475A5B0AQ37042411-2902721A-7060-412F-B3CF-815DE9BF56F7Q37276666-625109B0-5446-4BC2-9142-9A4A4583814CQ37289819-2C2D5642-52B6-41CC-B655-EF1275B868D6Q37611748-C2F90631-EC76-4012-B050-6E160DD3E2D6Q37724193-6A328692-B538-4211-8CD9-0306DA8E7641
P2860
Alprazolam in panic disorder and agoraphobia: results from a multicenter trial. I. Efficacy in short-term treatment.
description
1988 nî lūn-bûn
@nan
1988年の論文
@ja
1988年論文
@yue
1988年論文
@zh-hant
1988年論文
@zh-hk
1988年論文
@zh-mo
1988年論文
@zh-tw
1988年论文
@wuu
1988年论文
@zh
1988年论文
@zh-cn
name
Alprazolam in panic disorder a ...... icacy in short-term treatment.
@en
type
label
Alprazolam in panic disorder a ...... icacy in short-term treatment.
@en
prefLabel
Alprazolam in panic disorder a ...... icacy in short-term treatment.
@en
P2093
P1433
P1476
Alprazolam in panic disorder a ...... icacy in short-term treatment.
@en
P2093
Ballenger JC
Burrows GD
DuPont RL Jr
Noyes R Jr
Pecknold JC
Swinson RP
P304
P356
10.1001/ARCHPSYC.1988.01800290027004
P407
P577
1988-05-01T00:00:00Z